Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features

被引:0
作者
Lei Miao
Shu-Tao Ma
Xu Jiang
Huan-Huan Zhang
Yan-Mei Wang
Meng Li
机构
[1] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Department of Diagnostic Radiology
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[4] GE Healthcare China,undefined
来源
BMC Medical Imaging | / 22卷
关键词
Radiomics; Soft tissue sarcoma; Lung metastases; Efficacy prediction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 204 条
[1]  
Siegel RL(2021)Cancer statistics, 2021 CA Cancer J Clin 71 7-33
[2]  
Miller KD(2021)The 2020 WHO classification of soft tissue tumours: news and perspectives Pathologica 113 70-84
[3]  
Fuchs HE(2001)Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group Cancer 91 1914-1926
[4]  
Jemal A(2011)Trends in survival for patients with metastatic soft-tissue sarcoma Cancer 117 1049-1054
[5]  
Sbaraglia M(1993)Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma Ann Surg 218 705-712
[6]  
Bellan E(2018)Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: an exploratory, retrospective analysis of the European organization for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC-STBSG) Int J Cancer 142 2610-2620
[7]  
Dei Tos AP(2021)SEOM clinical guideline of management of soft-tissue sarcoma (2020) Clin Transl Oncol 23 922-930
[8]  
Coindre JM(2016)Chemotherapy for soft tissue sarcoma Cancer 122 2952-2960
[9]  
Terrier P(1994)Clinical pharmacokinetics of epirubicin Clin Pharmacokinet 26 428-438
[10]  
Guillou L(2016)RECIST 1.1-update and clarification: from the RECIST committee Eur J Cancer 62 132-137